INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

AUPHAurinia Pharmaceuticals Inc.

CIK 0001600620

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 1
Max Insider Score27
Connections5with evidence

AUPH · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
RP
Robertson Stephen P.Chief Legal Officer
AUPHAurinia Pharmaceuticals Inc.
Open-market sale
SELL$356K
21.0K sh
Aug 21, 2026Aug 25, 2026
traded Aug 21, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Goetz KathleenDirector · Jun 8, 2026
  • ← Insider ofevidence
    Cole RyanChief Operating Officer · May 20, 2026
  • ← Insider ofevidence
    Robertson Stephen P.Chief Legal Officer · May 20, 2026
  • ← Insider ofevidence
9
GK
Goetz KathleenDirector
AUPHAurinia Pharmaceuticals Inc.
Grant or award
A
—
23.9K sh
Jun 4, 2026
Jun 8, 2026
traded Jun 4, 2026
+4d
SEC FORM 4

Evidence

9
CR
Cole RyanChief Operating Officer
AUPHAurinia Pharmaceuticals Inc.
Grant or award
A—
116.1K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

9
CR
Cole RyanChief Operating Officer
AUPHAurinia Pharmaceuticals Inc.
Grant or award
A—
70.2K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

17
RP
Robertson Stephen P.Chief Legal Officer
AUPHAurinia Pharmaceuticals Inc.
Grant or award
A—
115.5K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

16
KG
Keenan GregSVP, Chief Medical Officer
AUPHAurinia Pharmaceuticals Inc.
Tax withholding
F$168K
11.6K sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC FORM 4

Evidence

Keenan Greg
SVP, Chief Medical Officer · Feb 3, 2026